Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

June 15, 2022; Volume 19,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

C

  1. Cao, Yandong

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  2. Chai, Junyue

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  3. Chen, Haizhu

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
  4. Chen, Kexin

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  5. Cheng, Jiamin

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661
  6. Cheng, Yanan

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

D

  1. Dong, Li

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  2. Dong, Yang

    1. You have access
      Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598

F

  1. Feng, Ru

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

G

  1. Ge, Shuang

    1. You have access
      EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371
  2. Gui, Lin

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
  3. Guo, Qian

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

H

  1. Han, Lei

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  2. Hao, Xishan

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  3. He, Xiaohui

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
  4. Hu, Gaoyong

    1. You have access
      Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006
  5. Hu, Wei

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  6. Huang, Manru

    1. You have access
      Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006

I

  1. Im, Jung Ho

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

J

  1. Jeong, Bae Kwon

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
  2. Jiang, Hongxin

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
  3. Jiang, Shiyu

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
  4. Jiang, Zefei

    1. You have access
      Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
      Jianbin Li and Zefei Jiang
      Cancer Biology & Medicine June 2022, 19 (6) 769-773; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0277
  5. Jing, Hongmei

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  6. Jing, Xiaotong

    1. You have access
      EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371
  7. Jing, Yi

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

K

  1. Kim, Byoung Hyuck

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
  2. Kim, Jin Hee

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
  3. Kim, Kyubo

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
  4. Kim, Tae Gyu

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
  5. Kim, Tae Hyun

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
  6. Kim, Woo Chul

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
  7. Kim, Youngkyong

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

L

  1. Lee, Sung Uk

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
  2. Li, Fengtong

    1. You have access
      Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598
  3. Li, Hailing

    1. You have access
      EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371
  4. Li, Jianbin

    1. You have access
      Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
      Jianbin Li and Zefei Jiang
      Cancer Biology & Medicine June 2022, 19 (6) 769-773; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0277
  5. Li, Jiangtao

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  6. Li, Lijuan

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  7. Li, Qi

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  8. Li, Shixia

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  9. Li, Ting

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  10. Li, Wenliang

    1. You have access
      Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598
  11. Li, Xia

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  12. Li, Xiangchun

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  13. Liang, Ke

    1. You have access
      EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371
  14. Liao, Zhichao

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  15. Lin, Wei

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  16. Liu, Caiyan

    1. You have access
      Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006
  17. Liu, Hui

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  18. Liu, Juntian

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  19. Liu, Peng

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
  20. Liu, Qun

    1. You have access
      Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598
  21. Lu, Jia

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  22. Lu, Yinying

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

M

  1. Mo, Xiaodong

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

N

  1. Nam, Taek-Keun

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

P

  1. Park, Hae Jin

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
  2. Peng, Caiyun

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661
  3. Pu, Weiling

    1. You have access
      Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006

Q

  1. Qin, Yan

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

R

  1. Ren, Zhiwu

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  2. Ru, Yi

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

S

  1. Seong, Jinsil

    1. You have access
      Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
  2. Shao, Yingying

    1. You have access
      Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006
  3. Shen, Mengzhu

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  4. Shi, Xiaoliang

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661
  5. Shi, Yuankai

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
  6. Su, Guodong

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

T

  1. Teng, Sheng

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  2. Trent, Jonathan

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

W

  1. Wan, Wei

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  2. Wang, He

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  3. Wang, Jiancai

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  4. Wang, Jingwen

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  5. Wang, Jun

    1. You have access
      EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371
  6. Wang, Liru

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  7. Wang, Qinhao

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  8. Wang, Xiaoguang

    1. You have access
      Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598
  9. Wei, Lijuan

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  10. Wu, Guojun

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  11. Wu, Haixiao

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  12. Wu, Tong

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

X

  1. Xia, Mingyuan

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  2. Xing, Ruwei

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  3. Xiong, Xin

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  4. Xu, Hui

    1. You have access
      EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371
  5. Xue, Chaoshuai

    1. You have access
      EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371

Y

  1. Yan, Fengqi

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  2. Yan, Guang

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  3. Yan, Tao

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661
  4. Yang, Jianliang

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
  5. Yang, Jilong

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  6. Yang, Yun

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  7. Ye, Yingnan

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  8. Yin, Qiang

    1. You have access
      Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598
  9. Yin, Shuangshuang

    1. You have access
      Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006
  10. Yu, Haiyang

    1. You have access
      Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006
  11. Yu, Hui

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  12. Yu, Jinpu

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  13. Yu, Lingxiang

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

Z

  1. Zhang, Bo

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  2. Zhang, Changgong

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
  3. Zhang, Chunli

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  4. Zhang, Cuijuan

    1. You have access
      EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371
  5. Zhang, Hailian

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  6. Zhang, Huan

    1. You have access
      The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
  7. Zhang, Linzhi

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661
  8. Zhang, Mei

    1. You have access
      MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
  9. Zhang, Ning

    1. You have access
      The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661
  10. Zhang, Shuai

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  11. Zhang, Xiaoying

    1. You have access
      EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371
  12. Zhao, Jun

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  13. Zhao, Yongtian

    1. You have access
      The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  14. Zhong, Yuping

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  15. Zhou, Hebing

    1. You have access
      Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
  16. Zhou, Liqiang

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
  17. Zhou, Shengyu

    1. You have access
      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
  18. Zhou, Shiyue

    1. You have access
      Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 19 (6)
Cancer Biology & Medicine
Vol. 19, Issue 6
15 Jun 2022
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire